TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Alfresa Holdings ( (JP:2784) ) has issued an announcement.
Alfresa Holdings has announced its 25–27 Mid-term Management Plan, part of its Vision 2032 Stage 2, which focuses on strengthening core businesses and expanding its supply chain services. The plan includes strategic investments in growth and new businesses, rigorous cost control, and sustainability management to enhance corporate value and ensure a stable supply chain.
The most recent analyst rating on (JP:2784) stock is a Hold with a Yen2120.00 price target. To see the full list of analyst forecasts on Alfresa Holdings stock, see the JP:2784 Stock Forecast page.
More about Alfresa Holdings
Alfresa Holdings Corporation operates in the healthcare industry, focusing on pharmaceuticals and healthcare-related services. The company aims to extend healthy life expectancies and contribute to community healthcare through innovative business strategies and a comprehensive supply chain service model.
Average Trading Volume: 511,221
Technical Sentiment Signal: Strong Buy
Current Market Cap: Yen414.9B
Learn more about 2784 stock on TipRanks’ Stock Analysis page.